Study uncovers key processes behind MYC cancer gene
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
List view / Grid view
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
A new study has identified possible regulators that determine differences in cancer tumours between genders.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
Researchers have identified the process behind cancer cell energy production, providing a drug target for treatments to inhibit growth.
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
New study sheds light on how the TP53 gene becomes mutated and how those mutations can help predict clinical outlooks for cancer.
Researchers have identified a key process behind senescence, or why cells age, which could be used to improve treatments for cancer.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
Researchers have found that fat cells transfer cytokines to melanoma cells, which transforms them into aggressive tumours, indicating a drug target for the condition.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.